GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Beginning Cash Position

Alto Neuroscience (Alto Neuroscience) Beginning Cash Position : $82.55 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Beginning Cash Position?

Alto Neuroscience's Beginning Cash Position for the quarter that ended in Mar. 2024 was $82.55 Mil.

Alto Neuroscience's quarterly Beginning Cash Position increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($51.29 Mil) and increased from Dec. 2023 ($51.29 Mil) to Mar. 2024 ($82.55 Mil).

Alto Neuroscience's annual Beginning Cash Position increased from Dec. 2021 ($4.01 Mil) to Dec. 2022 ($25.71 Mil) and increased from Dec. 2022 ($25.71 Mil) to Dec. 2023 ($48.34 Mil).

Alto Neuroscience Beginning Cash Position Historical Data

The historical data trend for Alto Neuroscience's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Beginning Cash Position Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Beginning Cash Position
4.01 25.71 48.34

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial 34.70 48.34 - 51.29 82.55

Alto Neuroscience Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Alto Neuroscience Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Beginning Cash Position
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024